XML 20 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating Revenues:        
Total revenues $ 113,168 $ 90,423 $ 317,040 $ 258,191
Operating Expenses:        
Compensation and benefits 29,405 27,955 91,249 81,672
Fund management and administration 21,004 18,023 61,105 52,903
Marketing and advertising 4,897 3,833 14,415 12,305
Sales and business development 3,465 3,383 10,716 9,703
Contractual gold payments (Note 9) 6,069
Professional fees 6,315 3,719 16,539 15,768
Occupancy, communications and equipment 1,397 1,203 3,921 3,476
Depreciation and amortization 447 307 1,248 537
Third-party distribution fees 2,983 2,694 7,977 6,828
Other 2,463 2,601 7,617 7,473
Total operating expenses 72,376 63,718 214,787 196,734
Operating income 40,792 26,705 102,253 61,457
Other Income/(Expenses):        
Interest expense (5,027) (3,461) (13,295) (11,484)
Gain on revaluation/termination of deferred consideration—gold payments (Note 9) 61,953
Interest income 1,795 791 4,631 2,874
Impairments (Note 25) (2,703) (7,603)
Loss on extinguishment of convertible notes (Note 10) (30,632) (30,632) (9,721)
Other losses, net (3,062) (2,512) (1,753) (3,233)
Income before income taxes 3,866 18,820 61,204 94,243
Income tax expense 8,351 5,836 21,819 10,774
Net (loss)/income $ (4,485) $ 12,984 $ 39,385 $ 83,469
(Loss)/earnings per share—basic (in Dollars per share) $ (0.13) $ 0.07 $ 0.16 $ 0.5
(Loss)/earnings per share—diluted (in Dollars per share) $ (0.13) $ 0.07 $ 0.16 $ 0.49
Weighted-average common shares—basic (in Shares) 143,929 145,284 145,756 144,505
Weighted-average common shares—diluted (in Shares) 143,929 [1] 177,140 162,691 169,997
Cash dividends declared per common share (in Dollars per share) $ 0.03 $ 0.03 $ 0.09 $ 0.09
Advisory fees        
Operating Revenues:        
Operating Revenues $ 101,659 $ 86,598 $ 293,098 $ 246,239
Other revenues        
Operating Revenues:        
Operating Revenues $ 11,509 $ 3,825 $ 23,942 $ 11,952
[1] Excludes 7,540 participating securities and 5,276 potentially dilutive non-participating common stock equivalents for the three months ended September 30, 2024, as the Company reported a net loss for the period (shares herein are reported in thousands).